Skip to content
Home/GPs/Asabys Partners
Asabys Partners

Asabys Partners

Barcelona, Spain·Founded 2018··asabys.com

Asabys Partners is a Barcelona-based venture capital firm founded in 2018 by Josep Ll. Sanfeliu and Clara Campas that invests in early-stage biopharma, medical device and digital health companies in Spain and internationally, anchored by Banco Sabadell through its Sabadell Asabys Health Innovation Investments fund family.

AUM
€300M
Funds
2
vintages 2019–2023
Portfolio
18
Exits
3
SectorsHealthcare

Key facts

HQBarcelona, Spain
Founded2018
Employees17+
Websiteasabys.com

Recent exits

Agomab
Agomab
Biotech2026 · 5yr hold
Amelia
HealthTech2023 · 4yr hold
Origo Biopharma
Biotech2021 · 1yr hold

Coverage notes

2 funds tracked, 21 portfolio companies (18 active · 3 realized). Verified weekly from public filings and deal announcements.

Sector breakdown

21 companies
Biotech
10 · 48%
MedTech
6 · 29%
HealthTech
5 · 24%

Funds & portfolio

Every fund Asabys Partners has raised, with its portfolio companies. Hand-checked from public filings.

2 funds
Sabadell Asabys Health Innovation Investments IILife Sciences VC
2023 · 3yr€180M9 active

Unrealized

9 held
ALLOX
AlloxActive
BiotechSpain· Entry 2023
BiotechBelgium· Entry 2024
DeepullActive
MedTechSpain· Entry 2023
MedTechFrance· Entry 2023
BiotechSpain· Entry 2023
Orikine BioActive
BiotechSpain· Entry 2023
BiotechSpain· Entry 2026
QuibimActive
HealthTechSpain· Entry 2025
SafeHeal
SafeHealActive
MedTechFrance· Entry 2025
Sabadell Asabys Health Innovation InvestmentsLife Sciences VCHarvesting
2019 · 7yr€117M9 active · 3 realized

Unrealized

9 held
BiotechSpain· Entry 2025
MedTechSpain· Entry 2019
MedTechSpain· Entry 2020
Medasense
MedasenseActive
MedTechIsrael· Entry 2020
BiotechSpain· Entry 2019
QidaActive
HealthTechSpain· Entry 2025
HealthTechIceland· Entry 2020
Splice Bio
Splice BioActive
BiotechSpain· Entry 2022
XRHealth
XRHealthActive
HealthTechUnited States· Entry 2023

Realized

3 exits
Agomab
AgomabExited 2026
BiotechBelgium· Entry 2021
IPO
AmeliaExited 2023
HealthTechSpain· Entry 2019
Trade Saleto
Origo BiopharmaExited 2021
BiotechSpain· Entry 2020
Trade Saleto
Track Asabys Partners

Saved GPs appear in your watchlist, one click from your workspace.

Get the full picture on Asabys Partners.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Save this GP to your watchlist
Saved searches that re-run your sourcing filters in one click
Geography breakdown across 6 geographies
Exit buyers and MOIC on every realized deal (Pro)
Export, compare GPs side by side (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Last updated August 2026 · Sourced from public filings · Report an issue